# US 2019/0167766 A1 · Formulations for Nutritional Support in Subjects in Need Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167766 A1
- Document ID: US20190167766A1
- Status: Published application
- Kind: A1
- Application number: 15/829,703
- Filed: 2017-12-01
- Published: 2019-06-06
- Earliest claimed: 2017-12-01
- Assignees: Second Science, Inc.
- Applicants: Second Science, Inc.
- Inventors: Ron Belldegrun; Mia Funt
- Web page: https://patentgrep.com/patent/US20190167766A1

## CPC

- A61K 38/40: Transferrins, e.g. lactoferrins, ovotransferrins
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/18: Peptides; Protein hydrolysates
- A23L 33/19: Dairy proteins
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 38/018: {from milk}
- A61K 38/19: Cytokines; Lymphokines; Interferons
- A61K 38/38: Albumins
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Formulations having a protein component, in which the protein contains one or more digestion-aiding proteins, and/or one or more immunoprotective proteins. The formulations may also contain a fat component, a carbohydrate component, and vitamins and minerals. These formulations can be used to provide nutritional support to a subject, either as dietary supplements or as a primary source of nutrition, such as for an infant formula.

## Claims

### Claim at position 1

1-117. (canceled)

### Claim 118

A formulation for oral administration comprising a protein component, wherein the protein component comprises:
(a) one or more digestion-aiding proteins, selected from the group consisting of whey protein hydrolysate (WPH) protein, alpha-lactalbumin, and κ-casein; and
(b) one or more immunoprotective proteins, selected from the group consisting of lactoferrin, osteopontin, κ-casein, haptocorrin, lysozyme, secretory IgA, and bile-salt stimulated lipase;
wherein the one or more digestion-aiding proteins and the one or more immunoprotective proteins comprise about 5% to about 95% by weight of the protein component; and
wherein the formulation further comprises a milk component comprising milk from a non-human source.

### Claim at position 3

119-171. (canceled)

### Claim 172 (depends on 118)

The formulation of claim 118, wherein the one or more digestion-aiding proteins comprise WPH protein and alpha-lactalbumin.

### Claim 173 (depends on 172)

The formulation of claim 172, wherein the WPH protein and the alpha-lactalbumin are present in a ratio of about 4:1 to about 1:1 by weight.

### Claim 174 (depends on 172)

The formulation of claim 172, wherein the WPH protein and the alpha-lactalbumin comprise about 30% to about 70% by weight of the protein component.

### Claim 175 (depends on 174)

The formulation of claim 174, wherein the WPH protein comprises about 20% to about 50% by weight of the protein component.

### Claim 176 (depends on 174)

The formulation of claim 174, wherein the alpha-lactalbumin comprises about 10% to about 20% by weight of the protein component.

### Claim 177 (depends on 118)

The formulation of claim 118, wherein the one or more immunoprotective proteins comprise lactoferrin and osteopontin.

### Claim 178 (depends on 177)

The formulation of claim 177, wherein the lactoferrin and osteopontin are present in a ratio of about 10:1 to about 5:1 by weight.

### Claim 179 (depends on 177)

The formulation of claim 177, wherein the lactoferrin and osteopontin comprise about 4% to about 12% by weight of the protein component.

### Claim 180 (depends on 179)

The formulation of claim 179, wherein the lactoferrin comprises about 4% to about 10% by weight of the protein component.

### Claim 181 (depends on 179)

The formulation of claim 179, wherein the osteopontin comprises about 0.1% to about 2% by weight of the protein component.

### Claim 182 (depends on 118)

The formulation of claim 118, wherein the milk comprises bovine milk.

### Claim 183 (depends on 182)

The formulation of claim 182, wherein the milk comprises whole milk.

### Claim 184 (depends on 182)

The formulation of claim 182, wherein the milk is in an amount to provide about 15% to about 25% by weight of the protein component.

### Claim 185 (depends on 118)

The formulation of claim 118, further comprising a fat component.

### Claim 186 (depends on 185)

The formulation of claim 185, wherein the fat component comprises innate milk fat globule membrane, added milk fat globule membrane, phospholipids, cholesterol, oil, non-hexane extracted docosahexaenoic acid, hexane extracted arachidonic acid, non-hexane extracted arachidonic acid, or a combination thereof.

### Claim 187 (depends on 118)

The formulation of claim 118, further comprising a carbohydrate component.

### Claim 188 (depends on 187)

The formulation of claim 187, wherein the carbohydrate component comprises lactose, galactooligosaccharide, fructooligosaccharide, inulin, corn syrup solids, maltodextrin, or a combination thereof.

### Claim 189 (depends on 118)

The formulation of claim 118, wherein the formulation is in powder form.

### Claim 190

A formulation for oral administration comprising a protein component, a fat component, a carbohydrate component, and milk from a bovine source, wherein:
(a) the protein component comprises whey protein hydrolysate (WPH) protein, alpha-lactalbumin, lactoferrin, and osteopontin, wherein the WPH protein comprises about 20% to about 50% by weight of the protein component, the alpha-lactalbumin comprises about 10% to about 20% by weight of the protein component, the lactoferrin comprises about 6% to about 9% by weight of the protein component, and the osteopontin comprises about 0.5% to about or about 1.5% by weight of the protein component;
(b) the fat component comprises innate milk fat globule membrane, added milk fat globule membrane, phospholipids, non-hexane extracted docosahexaenoic acid, hexane extracted arachidonic acid, non-hexane extracted arachidonic acid, or a combination thereof;
(c) the carbohydrate component comprises lactose and galactooligosaccharide; and
(d) the whole milk is in an amount to provide about 15% or about 25% by weight of the protein component.
